Date Action Amount Person Type
Apr 12, 2024 Sell 695 339 Subramaniam Somu Common Stock
Apr 12, 2024 Sell 695 339 Nsv Partners Iii Lp Common Stock
Apr 02, 2024 Sell 1 651 Krueger Christopher W Common Stock
Apr 02, 2024 Sell 1 651 Nuss John Common Stock
Apr 02, 2024 Sell 4 312 Mohan Raju Common Stock
Apr 02, 2024 Sell 1 405 Auster Martin Common Stock
Mar 28, 2024 Buy 4 531 Krueger Christopher W Common Stock
Mar 28, 2024 Sell 4 531 Krueger Christopher W Restricted Stock Units
Mar 28, 2024 Buy 4 531 Auster Martin Common Stock
Mar 28, 2024 Sell 4 531 Auster Martin Restricted Stock Units
Mar 28, 2024 Buy 11 843 Mohan Raju Common Stock
Mar 28, 2024 Sell 11 843 Mohan Raju Restricted Stock Units
Mar 28, 2024 Buy 4 531 Nuss John Common Stock
Mar 28, 2024 Sell 4 531 Nuss John Restricted Stock Units
Jan 21, 2024 Buy 20 000 White William Richard Stock Option (right to buy)
Jan 21, 2024 Buy 20 000 Subramaniam Somu Stock Option (right to buy)
Jan 21, 2024 Buy 20 000 Hulme Allison Stock Option (right to buy)
Jan 21, 2024 Buy 20 000 Cadoret-manier Onaiza Stock Option (right to buy)
Jan 21, 2024 Buy 80 000 Gujrathi Sheila Stock Option (Right to Buy)
Jan 02, 2024 Buy 125 000 Auster Martin Stock Option (right to buy)
Jan 02, 2024 Buy 155 000 Mohan Raju Stock Option (Right to Buy)
Jan 02, 2024 Buy 125 000 Nuss John Stock Option (Right to Buy)
Jan 02, 2024 Buy 125 000 Krueger Christopher W Stock Option (Right to Buy)
Dec 20, 2023 Sell 17 628 Nuss John Common Stock
Dec 20, 2023 Sell 5 293 Krueger Christopher W Common Stock
Dec 20, 2023 Sell 58 860 Mohan Raju Common Stock
Dec 18, 2023 Buy 473 750 Mohan Raju Stock Option (Right to Buy)
Dec 18, 2023 Buy 181 250 Nuss John Stock Option (Right to Buy)
Dec 18, 2023 Buy 181 250 Krueger Christopher W Stock Option (Right to Buy)
Dec 18, 2023 Buy 181 250 Auster Martin Stock Option (right to buy)
Dec 17, 2023 Buy 116 668 Mohan Raju Common Stock
Dec 17, 2023 Sell 116 668 Mohan Raju Restricted Stock Units
Dec 17, 2023 Buy 34 931 Nuss John Common Stock
Dec 17, 2023 Sell 34 931 Nuss John Restricted Stock Units
Dec 17, 2023 Buy 10 479 Krueger Christopher W Common Stock
Dec 17, 2023 Sell 10 479 Krueger Christopher W Restricted Stock Units
Oct 09, 2023 Sell 49 152 Nsv Partners Iii Lp Common Stock
Oct 09, 2023 Sell 49 152 Subramaniam Somu Common Stock
Oct 05, 2023 Buy 30 000 Mohan Raju Common Stock
Oct 05, 2023 Sell 30 000 Mohan Raju Common Stock
Oct 05, 2023 Sell 30 000 Mohan Raju Stock Option (Right to Buy)
Oct 03, 2023 Buy 15 000 Krueger Christopher W Common Stock
Oct 03, 2023 Sell 14 006 Krueger Christopher W Common Stock
Oct 03, 2023 Sell 994 Krueger Christopher W Common Stock
Oct 03, 2023 Sell 15 000 Krueger Christopher W Stock Option (Right to Buy)
Oct 03, 2023 Buy 627 Nuss John Common Stock
Oct 03, 2023 Buy 7 972 Nuss John Common Stock
Oct 03, 2023 Buy 1 401 Nuss John Common Stock
Oct 03, 2023 Sell 9 277 Nuss John Common Stock
Oct 03, 2023 Sell 723 Nuss John Common Stock
Oct 03, 2023 Sell 627 Nuss John Stock Option (right to buy)
Oct 03, 2023 Sell 1 401 Nuss John Stock Option (right to buy)
Oct 03, 2023 Sell 7 972 Nuss John Stock Option (right to buy)
Sep 18, 2023 Sell 56 665 Subramaniam Somu Common Stock
Sep 18, 2023 Sell 56 665 Nsv Partners Iii Lp Common Stock
Sep 05, 2023 Sell 18 327 Auster Martin Common Stock
Sep 05, 2023 Sell 8 142 Auster Martin Common Stock
Sep 05, 2023 Sell 3 Auster Martin Common Stock
Sep 05, 2023 Buy 15 000 Krueger Christopher W Common Stock
Sep 05, 2023 Sell 10 431 Krueger Christopher W Common Stock
Sep 05, 2023 Sell 4 546 Krueger Christopher W Common Stock
Sep 05, 2023 Sell 23 Krueger Christopher W Common Stock
Sep 05, 2023 Sell 15 000 Krueger Christopher W Stock Option (Right to Buy)
Sep 05, 2023 Buy 30 000 Mohan Raju Common Stock
Sep 05, 2023 Sell 20 630 Mohan Raju Common Stock
Sep 05, 2023 Sell 9 015 Mohan Raju Common Stock
Sep 05, 2023 Sell 355 Mohan Raju Common Stock
Sep 05, 2023 Sell 30 000 Mohan Raju Stock Option (Right to Buy)
Sep 05, 2023 Buy 10 000 Nuss John Common Stock
Sep 05, 2023 Sell 6 991 Nuss John Common Stock
Sep 05, 2023 Sell 3 009 Nuss John Common Stock
Sep 05, 2023 Sell 10 000 Nuss John Stock Option (right to buy)
Aug 31, 2023 Sell 11 900 Sandborn William J. Stock Option (Right to Buy)
Aug 31, 2023 Buy 11 900 Sandborn William J. Common Stock
Aug 31, 2023 Sell 11 900 Sandborn William J. Common Stock
Aug 08, 2023 Sell 2 086 Sandborn William J. Common Stock
Aug 08, 2023 Sell 1 408 Sandborn William J. Common Stock
Aug 07, 2023 Buy 30 000 Mohan Raju Common Stock
Aug 07, 2023 Sell 20 225 Mohan Raju Common Stock
Aug 07, 2023 Sell 8 898 Mohan Raju Common Stock
Aug 07, 2023 Sell 877 Mohan Raju Common Stock
Aug 07, 2023 Sell 30 000 Mohan Raju Stock Option (Right to Buy)
Aug 03, 2023 Buy 10 000 Nuss John Common Stock
Aug 03, 2023 Sell 8 887 Nuss John Common Stock
Aug 03, 2023 Sell 1 113 Nuss John Common Stock
Aug 03, 2023 Sell 10 000 Nuss John Stock Option (right to buy)
Aug 03, 2023 Buy 15 000 Krueger Christopher W Common Stock
Aug 03, 2023 Sell 13 300 Krueger Christopher W Common Stock
Aug 03, 2023 Sell 1 700 Krueger Christopher W Common Stock
Aug 03, 2023 Sell 15 000 Krueger Christopher W Stock Option (Right to Buy)
Jul 31, 2023 Sell 10 803 Subramaniam Somu Common Stock
Jul 31, 2023 Sell 10 803 Nsv Partners Iii Lp Common Stock
Jul 31, 2023 Sell 11 900 Sandborn William J. Stock Option (Right to Buy)
Jul 31, 2023 Buy 11 900 Sandborn William J. Common Stock
Jul 31, 2023 Sell 11 900 Sandborn William J. Common Stock
Jul 28, 2023 Sell 611 Subramaniam Somu Common Stock
Jul 28, 2023 Sell 611 Nsv Partners Iii Lp Common Stock
Jul 25, 2023 Sell 28 000 Auster Martin Stock Option (right to buy)
Jul 03, 2023 Sell 1 089 Krueger Christopher W Stock Option (Right to Buy)
Jul 03, 2023 Sell 13 911 Krueger Christopher W Stock Option (Right to Buy)
INSIDER POWER
-9.147
Last 100 transactions
Buy: 2 083 814 | Sell: 2 354 020 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be negative at a ratio of -9.147.

In total, the insiders bought 2 083 814 and sold 2 354 020 VTYX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Ventyx Biosciences, Inc.

Ventyx Biosciences. Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis, inflammatory bowel disease, psoriatic arthritis, Crohn's disease, and lupus. It also develops VTX002,... VTYX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT